Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505.

Itoh, K

Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Sep 2002 - 1347-55 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0923-7534

10.1093/annonc/mdf287 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Confidence Intervals
Cyclophosphamide--administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Doxorubicin--administration & dosage
Drug Administration Schedule
Female
Follow-Up Studies
Granulocyte Colony-Stimulating Factor--administration & dosage
Humans
Infusions, Intravenous
Japan
Lenograstim
Lymphoma, Non-Hodgkin--diagnosis
Male
Maximum Tolerated Dose
Middle Aged
Neutropenia--prevention & control
Prednisolone--administration & dosage
Probability
Recombinant Proteins--administration & dosage
Risk Assessment
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage